US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 7.650
  • -0.110-1.42%
Close Dec 20 16:00 ET
  • 7.650
  • 0.0000.00%
Post 16:12 ET
481.35MMarket Cap-2.15P/E (TTM)

Abivax S.A. Key Stats

Abivax S.A. Q3 2024 Estimates Date

Currency:EURNov 7, 2024

Estimate YoY
Revenue
3.41M
--
EPS
-0.65
--
Strong Buy

Dec 13, 2024

Abivax S.A. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.704M--
Nov 7, 20242024/Q3-- / 3.408M--
Sep 9, 20242024/Q2-- / 1.123M--
--2024/Q1-- / 1.123M--
--2019/Q120.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.704M--
Nov 7, 20242024/Q3-- / 3.408M--
Sep 9, 20242024/Q2-- / 1.123M--
--2024/Q1-- / 1.123M--
--2019/Q120.000K / 0.000--

Unlock Free Earnings Estimates

Abivax S.A. Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 13, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data